MedTrace Logo

Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues

NCT01585506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3618

Last updated 2018-02-07

No results posted yet for this study

Summary

This study is conducted in Europe. The aim of this study is to investigate psychosocial factors related to compliance with treatment with biphasic insulin analogues.

Conditions

Interventions

OTHER

No treatment given

Patients to complete the "WHO-5 Well-being Index" questionnaire

OTHER

No treatment given

Physicians to complete two questionnaires, "Demographic Data and Disease and Treatment Course" and "Questionnaire of Potential Difficulties in the Period of Treatment Switching from Insulin to Its Analogues"

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-20
Primary Completion
2010-12-20
Completion
2010-12-20

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585506 on ClinicalTrials.gov